Performance of Integrated FDG-PET/Contrast-enhanced CT in the Diagnosis of Recurrent Pancreatic Cancer: Comparison with Integrated FDG-PET/Non-contrast-enhanced CT and Enhanced CT
- 1 December 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Imaging & Biology
- Vol. 12 (4), 452-459
- https://doi.org/10.1007/s11307-009-0271-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Performance of integrated FDG–PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG–PET/non-contrast-enhanced CT and enhanced CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Surgery for Recurrent Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 2007
- Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.2005
- Integrated FDG PET/CT in Patients with Persistent Ovarian Cancer: Correlation with Histologic FindingsRadiology, 2004
- Accuracy of Whole-Body Dual-Modality Fluorine-18–2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Tumor Staging in Solid Tumors: Comparison With CT and PETJournal of Clinical Oncology, 2004
- Non-Hodgkin Lymphoma and Hodgkin Disease: Coregistered FDG PET and CT at Staging and Restaging—Do We Need Contrast-enhanced CT?Radiology, 2004
- PET-CT detection of abdominal recurrence of ovarian cancer: radiologic?surgical correlationAbdominal Radiology, 2004
- Pancreatic cancerThe Lancet, 2004
- Clinical Role of FDG PET in Evaluation of Cancer PatientsRadioGraphics, 2003